(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LP-33

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

LP-33

ST13

US500000085712295

Class

5

Filing

85712295

Registration

4371127

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

07/27/2023

Trademark type

Combined

Nice classes

5

Filing date

08/24/2012

Registration date

07/23/2013

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/27/2023

Last transaction

07/27/2023

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

03/18/2003

First use in commerce

07/21/2008

Drawing code

3

Owner type

03

Owner location

Tainan City, TW

Examiner

BENMAMAN, ALICE

Law office

M70

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of the letters "LP" in dark blue with oval design in light blue appearing inside the letter "P" and "-33" in dark blue.

Holders and representatives

Holders

GENMONT BIOTECH INC.
GENMONT BIOTECH INC.

Representatives

Zhi Dong Hamre, Schumann, Mueller & Larson, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medicine for bacteriological culturesfor treatment or improvement of allergy and for treatment of heart disease; lactobacillus for use in medicationfor treatment or improvement of allergy and for treatment of heart disease; lactobacillus for use in auxiliary therapy and nutritional supplementsfor treatment or improvement of allergy and for treatment of heart disease; allergy capsules; allergy relief medication; nutritional supplements; herbal supplements; food supplementsanti-oxidants; animal feed additive for use as a nutritional supplement

Publications

History of USPTO decisions and trademark events.

20 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

07/27/2023

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

07/27/2023

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

07/27/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/27/2023

E89R

TEAS SECTION 8 & 9 RECEIVED

01/09/2023

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/23/2022

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

02/02/2019

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

02/02/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/02/2019

ES8R

TEAS SECTION 8 RECEIVED

01/09/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

07/23/2013

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

06/14/2013

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

02/28/2013

PUBO

PUBLISHED FOR OPPOSITION

01/29/2013

NPUB

NOTICE OF PUBLICATION

01/09/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/18/2012

DOCK

ASSIGNED TO EXAMINER

12/18/2012

MDSC

NOTICE OF DESIGN SEARCH CODE MAILED

09/05/2012

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/04/2012

NWAP

NEW APPLICATION ENTERED

08/28/2012

Continuous trademark protection

Get notified about every new filing that threatens LP-33 or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.